Valvular heart diseases (VHDs) are currently treated using either mechanical or
bioprosthetic heart valves. Unfortunately, mechanical valves require lifelong anticoagulation …

Decellularized xenografts are an inherent component of regenerative medicine. Their
preserved structure, mechanical integrity and biofunctional composition have well …

Tissue-engineered heart valves (TEHVs) are emerging alternatives to current valve
prostheses and prospectively a lifelong replacement. Calcification, a pathological …

Objective Decellularized extracellular matrix made from porcine small intestinal submucosa,
commercially available as CorMatrix (CorMatrix Cardiovascular, Inc, Roswell, Ga) is used off …

The use of cardiovascular implants is commonplace in clinical practice. However,
reproducing the key bioactive and adaptive properties of native cardiovascular tissues with …

Cardiovascular tissue engineering (CVTE) aims to create living tissues, with the ability to
grow and remodel, as replacements for diseased blood vessels and heart valves. Despite …

In the last 25 years, numerous tissue engineered heart valve (TEHV) strategies have been
studied in large animal models. To evaluate, qualify and summarize all available …

Current heart valve replacements lack durability and prolonged performance, especially in
pediatric patients. In part, these problems may be attributed to the materials chosen for these …

Aims This short communication aims to review the treatment of cardiogenic shock in patients
with yew poisoning based on two case reports from our institution, focusing on the use of …

Background To describe the efficacy of four‐layer porcine small intestinal submucosa (Vetrix
BioSIS plus+) as single scaffold for the treatment of deep corneal lesions in dogs and cats …